85 related articles for article (PubMed ID: 28035725)
1. Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases.
Hung CM; Hsu YC; Chen TY; Chang CC; Lee MJ
Cell Biol Int; 2017 Mar; 41(3):345-352. PubMed ID: 28035725
[TBL] [Abstract][Full Text] [Related]
2. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
3. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.
Lechertier T; Berard M; Vassy R; Herve MA; Crepin M
Anticancer Res; 2004; 24(6):4011-7. PubMed ID: 15739262
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.
Altenburg JD; Siddiqui RA
Mol Cancer Res; 2009 Jul; 7(7):1013-20. PubMed ID: 19567784
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.
Wang LP; Jin J; Lv FF; Cao J; Zhang J; Wang BY; Shao ZM; Hu XC; Wang ZH
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1170-81. PubMed ID: 25912576
[TBL] [Abstract][Full Text] [Related]
7. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.
Yodkeeree S; Ampasavate C; Sung B; Aggarwal BB; Limtrakul P
Eur J Pharmacol; 2010 Feb; 627(1-3):8-15. PubMed ID: 19818349
[TBL] [Abstract][Full Text] [Related]
8. PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.
Gu S; Chen L; Hong Q; Yan T; Zhuang Z; Wang Q; Jin W; Zhu H; Wu J
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):771-8. PubMed ID: 21831961
[TBL] [Abstract][Full Text] [Related]
9. [The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].
Li HY; Ren GS; Tan JX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):393-7. PubMed ID: 19626989
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
Cui X; Chen J; Zacharek A; Li Y; Roberts C; Kapke A; Savant-Bhonsale S; Chopp M
Stem Cells; 2007 Nov; 25(11):2777-85. PubMed ID: 17641243
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
12. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
[TBL] [Abstract][Full Text] [Related]
13. Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
Zhao M; Mueller BM; DiScipio RG; Schraufstatter IU
Breast Cancer Res Treat; 2008 Jul; 110(2):211-22. PubMed ID: 17687643
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
15. Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro.
Zhang N; Zuo L; Zheng H; Li G; Hu X
Med Sci Monit; 2018 Aug; 24():5739-5747. PubMed ID: 30117494
[TBL] [Abstract][Full Text] [Related]
16. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
17. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
18. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
19. Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
Wang Y; Liang WC; Pan WL; Law WK; Hu JS; Ip DT; Waye MM; Ng TB; Wan DC
Phytomedicine; 2014 Sep; 21(11):1310-7. PubMed ID: 25172795
[TBL] [Abstract][Full Text] [Related]
20. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
